Tango Therapeutics Inc (TNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2009 | 03-2009 | |
| Cash Flows From Operating Activities | ||
| Net Income | -1,731 | -879 |
| Depreciation Amortization | 1,888 | 928 |
| Income taxes - deferred | 95 | 48 |
| Accounts receivable | -240 | -1,019 |
| Accounts payable and accrued liabilities | 91 | 405 |
| Other Working Capital | -788 | -211 |
| Other Operating Activity | 695 | 772 |
| Operating Cash Flow | $11 | $45 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -464 | -120 |
| Net Acquisitions | -965 | -937 |
| Investing Cash Flow | $-1,429 | $-1,056 |
| Cash Flows From Financing Activities | ||
| Debt Repayment | -58 | -15 |
| Common Stock Issued | 10 | 7 |
| Other Financing Activity | -85 | -33 |
| Financing Cash Flow | $-133 | $-41 |
| Beginning Cash Position | 6,554 | 6,554 |
| End Cash Position | 5,003 | 5,501 |
| Net Cash Flow | $-1,551 | $-1,053 |
| Free Cash Flow | ||
| Operating Cash Flow | 11 | 45 |
| Capital Expenditure | -464 | -120 |
| Free Cash Flow | -453 | -75 |